Research programme: anti-infectives - Clinical Data/VDDI

Drug Profile

Research programme: anti-infectives - Clinical Data/VDDI

Latest Information Update: 03 Apr 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of Alabama
  • Developer Clinical Data
  • Class
  • Mechanism of Action Nicotinamide adenine dinucleotide antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Anthrax

Most Recent Events

  • 20 Dec 2005 Icoria has been acquired and merged into Clinical Data
  • 24 Aug 2004 Paradigm Genetics is now called Icoria
  • 02 Apr 2002 Preclinical trials in Anthrax in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top